[1] Liao JK, Laufs U. Pleiotropic effects of stains[J]. Annu Rev Pharmacol Toxicol, 2005,45:89.
[2] Farwell WR,D'Avolio LW,Scranton RE,et al. Stains and prostate cancer diagnosis and grade in a veterans population[J].J Natl Cancer Inst, 2011, 103(11):885.
[3] Vaughan CJ, Gotto AM. Update on statins: 2003[J].Circulation, 2004, 110:886.
[4] Alonso R,Mata P. Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin[J].Atherosclerosis,2001, 157:423.
[5] Tsunekawa T,Hayashi T. Cerivastain,a hydroxymethylglutaryl coenzyme reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days[J].Circulation, 2001, 104:376.
[6] Williams JK, Sukhova GK, Herring DM, et al. Pravastain has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[J].J Am CollCardoil, 1998, 31:684.
[7] Endres M, Laufs U. Effects of statins on endothelium and signaling mechanisms[J].Stroke, 2004, 35:2708.
[8] Walter DH, Zeiher AM, Dimmeler S. Effects of statins on endothelim and their contribution to neovascularization by mobilization of endothelil progenitor cells[J].Coronary Artery Disease, 2004, 15:235.
[9] 陈巧玲,蔡宝祥.他汀类药物防治动脉粥样硬化作用研究进展[J].药学实践杂志,2006,24(6):321.
[10] Assmus B, Urbich C, Aicher A, et al. HMG-CoA Reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes[J].Circulation Res, 2003, 92:1049.
[11] Vasa M, Fichtlscherer S. Increase in circulating endotheliap progenitor cells by stain therapy in patients with stable coronary artery disease[J].Circulation, 2001, 103:2885.
[12] Fukumoto Y, Libby P, Rabkin E, et al. Stains alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits[J].Circulation, 2001, 103:993.
[13] Vincent L, Chen W, Hong L, et al. Inhibition of endothelial cell migration by cerivastation, an HMG-CoA reductase inhibitor:contribution to its anti-angiogenic effect[J].FEBS Lett, 2001, 495(3):159.
[14] Yamakawa T,Tanaka S,Kamei J,et al. Pitavsatatin inhibits vascular Smooth muscle cell proliferation by inactivating extracellular signal-regulated kinase 1/2[J].J Atheroscler Thromb,2003,10(1):37.
[15] Richard K. The Jupiter study, CRP screening, and aggressive statin therapy implications for the primary prevention of cardiovascular disease[J].Ther Adv Cardiovasc Dis, 2009,3(4):309.
[16] 李秋荣,王 勤,曲 环,等.瑞舒伐他汀对血脂正常的2型糖尿病患者血清高敏C 反应蛋白的作用[J].中华高血压杂志,2011,19(3):280.
[17] Bonetti PO, Lerman LO, et al. Stain effects beyond lipid lowering-are they clinically relevant?[J].European Heart Journal, 2003, 24(3):225.
[18] Giannotti G,Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis[J].Herz, 2007, 32(7):568.
[19] 陈 瑗,周 玫.氧化应激-炎症在动脉粥样硬化发生发展中作用研究的新进展[J].中国动脉硬化杂志,2008, 16(10):757.
[20] Hawk E, Viner JL. Statins and cancer—beyond the “one drug, one disease” model[J].N Engl J Med, 2005, 352(21):2184.
[21] 王 磊,胡昌华.他汀类药物抗癌作用新机制[J].中国药学杂志,2010,45(23):1796.
[22] Sassano A,Katsoulidis E,Antico G,et al. Suppressive effects of statins on actue promyelocytic leukemia cells[J].Cancer Res,2007, 67(9)4524.
[23] Weis M,Heeschen C,Glassford AJ,et al. Statins have biphasic effects on angiogenesis[J].Circulation,2002, 105:739.
[24] Fromigué O, Hamidouche Z, Marie PJ. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion[J]. J Biol Chem,2008, 284(45):30549.
[25] Cho SJ, Kim JS, Kim JM, et al. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts,and attenuates colitisassociated colon cancer in mice[J]. Int J Cancer, 2008, 123:951.
[26] 李 颖,张增叶,姜 达.洛伐他汀对恶性黑色素瘤B16细胞株的作用及其机制的研究[J]. 实用肿瘤学杂志,2008,6:520.
[27] 江庭秀,顾伟英,邱国强,等.辛伐他汀联合阿糖胞苷对K562细胞增殖与凋亡的影响[J].白血病·淋巴瘤,2011,20(1):35.
[28] 张 莉.他汀类药物调脂及非调脂作用的临床新进展[J].医学信息,2011,24(7):4248.
[29] Khurana V,Beijjanki HR,Caldito G,et al. Statins reduce the risk of lung cancer in humans,a large case-control study of US veterans[J]. Chest,2007, 131(5):1282.
[30] 吴苏舒,刘玉明,陈 静.他汀类药物调脂外临床应用概况[J].药学实践杂志,2007,25(1):4.